Mass Drug Administration of Ivermectin and Dihydroartemisinin-piperaquine as an Additional Intervention for Malaria Elimination

NCT03576313 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
4939
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

London School of Hygiene and Tropical Medicine

Collaborators